Clinical Characteristics, Anti-hyperglycaemic Treatment Pattern and Target Attainment of Type 2 Diabetes Mellitus Patients in Older Population With or Without Albuminuria in China: A Nationwide Cross-sectional Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,537
- 试验地点
- 18
- 主要终点
- Percentage of Patients Attained Blood Glucose Control Target Defined as Glycated Haemoglobin A1c (HbA1c)<7%, According to 2015 American Diabetes Association (ADA) and 2013 Chinese Diabetes Society (CDS) Guidelines.
研究概览
简要总结
This is a multi-centre, cross-sectional, non-interventional study assessing blood glucose target attainment, anti-hyperglycaemic treatment pattern and the clinical characteristics in older outpatients with Type 2 Diabetes Mellitus (T2DM) in hospitals of China. This study is designed to collect information of older T2DM patients in a real life setting
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 60 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Outpatient with confirmed T2DM
subjects with confirmed T2DM
干预措施: No Treatment (Drug)
结局指标
主要结局
Percentage of Patients Attained Blood Glucose Control Target Defined as Glycated Haemoglobin A1c (HbA1c)<7%, According to 2015 American Diabetes Association (ADA) and 2013 Chinese Diabetes Society (CDS) Guidelines.
时间窗: At study visit (one day)
The percentage of patients attaining blood glucose control target defined as HbA1c\<7%, according to 2015 American Diabetes Association (ADA) and 2013 Chinese Diabetes Society (CDS) guidelines.
次要结局
- Renal Function Level of Patients Measured by Estimated Glomerular Filtration Rate (eGFR)(At study visit (one day))
- Renal Function Level of Patients Measured by Albuminuria(At study visit (one day))
- Percentage of Patients With Lipid Lowering Therapy Usage(At study visit (one day))
- Renal Function Level of Patients Measured by Chronic Kidney Disease (CKD) Stage(At study visit (one day))
- Treatment Regimens for T2DM That Patient Are Currently Taking(At study visit (one day))
- Percentage of Patients Macro-vascular and Micro-vascular Diabetic Complications(At study visit (one day))
- Percentage of Patients With Hypoglycaemic Occurrence(At study visit (one day))
- Percentage of Patients With Hypoglycaemia Leading to Therapy Change(At study visit (one day))
- Follow up Duration of Type 2 Diabetes Related Risk Factors in Clinical Practice(At study visit (one day))
- Percentage of Patients With Anti-hypertension Therapy Usage(At study visit (one day))
- Percentage of Patients With Anti-platelet Therapy Usage(At study visit (one day))